COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study

COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study

Bibliographic Details
Main Authors: Filippo de Braud, Federico Nichetti, Marta Bini, Margherita Ambrosini, Arianna Ottini, Alessandro Rametta, Rita Leporati, Daniela Polastri, Chiara Pircher, Katia Dotti, Laura Ferrari
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/Suppl_3/e000883.full
id doaj-e685cff4a1dd44c491b9e65b3b6b6858
record_format Article
spelling doaj-e685cff4a1dd44c491b9e65b3b6b68582021-04-02T13:19:56ZengElsevierESMO Open2059-70292020-11-015Suppl 310.1136/esmoopen-2020-000883COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT studyFilippo de Braud0Federico Nichetti1Marta Bini2Margherita Ambrosini3Arianna Ottini4Alessandro Rametta5Rita Leporati6Daniela Polastri7Chiara Pircher8Katia Dotti9Laura Ferrari10Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, ItalyMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, Italyhttps://esmoopen.bmj.com/content/5/Suppl_3/e000883.full
collection DOAJ
language English
format Article
sources DOAJ
author Filippo de Braud
Federico Nichetti
Marta Bini
Margherita Ambrosini
Arianna Ottini
Alessandro Rametta
Rita Leporati
Daniela Polastri
Chiara Pircher
Katia Dotti
Laura Ferrari
spellingShingle Filippo de Braud
Federico Nichetti
Marta Bini
Margherita Ambrosini
Arianna Ottini
Alessandro Rametta
Rita Leporati
Daniela Polastri
Chiara Pircher
Katia Dotti
Laura Ferrari
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
ESMO Open
author_facet Filippo de Braud
Federico Nichetti
Marta Bini
Margherita Ambrosini
Arianna Ottini
Alessandro Rametta
Rita Leporati
Daniela Polastri
Chiara Pircher
Katia Dotti
Laura Ferrari
author_sort Filippo de Braud
title COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
title_short COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
title_full COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
title_fullStr COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
title_full_unstemmed COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
title_sort covid-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the national cancer institute of milan: the covint study
publisher Elsevier
series ESMO Open
issn 2059-7029
publishDate 2020-11-01
url https://esmoopen.bmj.com/content/5/Suppl_3/e000883.full
work_keys_str_mv AT filippodebraud covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT federiconichetti covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT martabini covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT margheritaambrosini covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT ariannaottini covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT alessandrorametta covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT ritaleporati covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT danielapolastri covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT chiarapircher covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT katiadotti covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
AT lauraferrari covid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy
_version_ 1721565421526581248

Similar Items